Live
10x Genomics Blog10x Genomics (TXG) Launches Atera: A Breakthrough in Spatial Bio - GuruFocus10x Genomics Blog10x Genomics announces Atera, a new in situ spatial biology platform - TipRanksAgilent11,390 Shares in Agilent Technologies, Inc. $A Acquired by Lecap Asset Management Ltd. - MarketBeatThermo FisherIs Thermo Fisher Scientific (TMO) Fairly Priced After Recent Share Price Rebound? - simplywall.stWatersPrecision Trading with Waters Corporation (WAT) Risk Zones - Stock Traders DailyLonza NewsLonza Group AG stock (CH0013841017): Why biopharma contract manufacturing now matters more for U.S. - AD HOC NEWS10x Genomics Blog10x Genomics Launches Atera Platform for Spatial Biology - Intellectia AILonza NewsLonza Group AG stock (CH0013841017): Is its biopharma contract strength enough for steady U.S. inves - AD HOC NEWS10x Genomics Blog10x Genomics Introduces Atera, a New Platform to Redefine How Biology is Measured and Understood - PR Newswire10x Genomics Blog10x Genomics Unveils Atera Spatial Platform at AACR Meeting - Genetic Engineering and Biotechnology News10x Genomics BlogOvervalued Tech Stocks? Texas Instruments, Jabil, 10x Genomics Face Scrutiny - News and Statistics - IndexBoxAgilentAgilent Stock Performance & Valuation Analysis 2026 | Business Review - News and Statistics - IndexBox
BioPharma Dive Mar 2, 2026

Roche pill succeeds in another MS study, but approval questions linger

Roche pill succeeds in another MS study, but approval questions linger

Original
Body unavailable. Use the original source.